Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Karyopharm Therapeutics Inc (NASDAQ:KPTI)

During the Trading Day
13.98 -0.21 / -1.48%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
13.98 -0.0017 / -0.01%
 
Volume: 3.8K
No recent news for Karyopharm Therapeutics Inc.

Today’s Trading

Previous close14.19
Today’s open13.91
Day’s range13.70 - 14.39
Volume255,325
Average volume (3 months)499,463
Market cap$506.7M
Dividend yield--
Data as of 3:59pm ET, 09/04/2015

Growth & Valuation

Earnings growth (last year)+56.53%
Earnings growth (this year)-37.45%
Earnings growth (next 5 years)-13.68%
Revenue growth (last year)-40.83%
P/E ratioNM
Price/Sales5,089.12
Price/Book2.24

Competitors

 Today’s
change
Today’s
% change
VNDAVanda Pharmaceutical...+0.18+1.51%
CARACara Therapeutics In...+0.08+0.42%
OTICOtonomy Inc+0.54+2.50%
CORTCorcept Therapeutics...-0.01-0.20%
Data as of 3:59pm ET, 09/04/2015

Financials

Next reporting dateNovember 9, 2015
EPS forecast (this quarter)-$0.86
Annual revenue (last year)$229.0K
Annual profit (last year)-$75.8M
Net profit margin-33,090.39%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michael G. Kauffman
President &
Chief Scientific Officer
Sharon Shacham
Corporate headquarters
Newton, Massachusetts

Forecasts

Partner Offers